12,851 resources
Start Prev Rows 8600 - 8800 Next
| Package | Version | Identity | Name/Title | Status | FMM | WG | Date | Auth | Source(s) |
|---|---|---|---|---|---|---|---|---|---|
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7672 | Performing Lab Type (Trich) | active | 2018-01 | tho oid | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7986 | Performing Lab Type (Anthrax) | active | 2020-01 | tho oid | |||
| us.cdc.phinvads | R4 | 2.16.840.1.113883.3.2074.1.1.3 | Race Category Excluding Nulls | active | 2013-01 | oid | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7724 | Personal Protective Equipment (RIBD) | active | 2018-01 | sct tho oid | |||
| hl7.fhir.us.davinci-drug-formulary | R4 | PharmacyBenefitTypeVS | Pharmacy benefit types | trial-use | phx | 2025-02 | hl7 | fhir | |
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.1075 | Physical Object | active | 2010-01 | sct | |||
| signal.core.r4 | R4 | questionnaire-ccars-place-of-residence | Questionnaire CCARS Place Of Residence | draft | 1 | pa | hl7 | ||
| hl7.fhir.us.vrdr | R4 | vrdr-place-of-injury-other-vs | Place of Injury - Other ValueSet | active | pher | 2024-10 | hl7 | fhir | |
| hl7.fhir.us.vrdr | R4 | vrdr-place-of-injury-vs | Place of Injury ValueSet | active | pher | 2024-10 | hl7 | tho loinc | |
| hl7.fhir.us.carin-bb | R4 | CMSPlaceofServiceCodes | CMS Place of Service Codes (POS) Value Set | trial-use | fm | 2025-02 | hl7 | cms | |
| hl7.fhir.us.mcode | R4 | tg263-vs | TG263 ValueSet | active | cic | 2025-02 | hl7 | fhir | |
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7376 | Ethnicity Detail (NCHS) | active | 2019-01 | tho oid | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7996 | Post-exposure or Treatment (NND) | active | 2020-01 | sct tho | |||
| fhir.virtually.healthcare | R4 | PractitionerIdentifiers | Practitioner Identifiers | draft | 2025-07 | hl7 | internal | ||
| fhir.nw-gmsa.nhs.uk | R4 | PractitionerIdentifiers | Practitioner Identifiers | draft | 2025-04 | hl7 | internal | ||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.8020 | Anthrax Vaccine Exposure (Anthrax) | active | 2020-01 | sct | |||
| signal.core.r4 | R4 | condition-clinical | Condition Clinical Status Codes | trial-use | 3 | pc | 2019-10 | hl7 | tho |
| signal.core.r4 | R4 | condition-severity | Condition/Diagnosis Severity | draft | pc | hl7 | sct | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.11.20.9.84 | Other Pregnancy Outcome | active | 2024-06 | hl7 | loinc | ||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.8040 | Pregnancy Outcome (Leptospirosis) | active | 2021-01 | sct tho | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7611 | Clinical Manifestations (STD) | active | 2019-12 | tho oid | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7191 | Syphilis Neurologic Involvement (STD) | active | 2020-01 | tho oid | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7441 | Neurological Manifestation (STD) | active | 2020-01 | sct tho | |||
| fhir.cdc.opioid-cds-r4 | R4 | barbiturate-urine-drug-screening-tests | Barbiturate urine drug screening tests | draft | 2024-04 | hl7 | |||
| fhir.cdc.opioid-cds-r4 | R4 | benzodiazepine-urine-drug-screening-tests | Benzodiazepine urine drug screening tests | draft | 2024-04 | hl7 | |||
| fhir.cdc.opioid-cds-r4 | R4 | buprenorphine-urine-drug-screening-tests | Buprenorphine urine drug screening tests | draft | 2024-04 | hl7 | |||
| fhir.cdc.opioid-cds-r4 | R4 | heroin-urine-drug-screening-tests | Heroin urine drug screening tests | draft | 2024-04 | hl7 | |||
| fhir.cdc.opioid-cds-r4 | R4 | general-opiate-urine-drug-screening-tests | General opiate urine drug screening tests | active | 2023-05 | hl7 | |||
| fhir.cdc.opioid-cds-r4 | R4 | oxycodone-urine-drug-screening-tests | Oxycodone urine drug screening tests | draft | 2024-04 | hl7 | |||
| hl7.fhir.us.vdor | R4 | vdor-previous-overdose-timing-vs | VDOR Previous Overdose Timing | informative | pher | 2025-06 | hl7 | fhir | |
| hl7.fhir.us.vdor | R4 | vdor-previous-overdose-vs | VDOR Previous Overdose | informative | pher | 2025-06 | hl7 | fhir | |
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7750 | Diagnosis Type (TB) | active | 2019-01 | sct | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7979 | Previous Treatment Duration (Hansen) | active | 2020-01 | tho oid | |||
| signal.core.r4 | R4 | questionnaire-ccars-previous-concurrent-services | Questionnaire CCARS Previous Concurrent Services | draft | 1 | pa | hl7 | ||
| fhir.org.nz.ig.base | R4 | pho | PHO | active | 2025-06 | hl7 | |||
| us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1021.101 | Gender Identity USCDI core | active | 2024-02 | hl7 | sct | ||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.3161 | Primary Reason For Evaluation (TB) | active | 2008-01 | sct tho oid | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.1035 | Reason Therapy Stopped (TB) | active | 2018-01 | sct tho oid | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.831 | Language | active | 2020-01 | tho | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.3315 | Travel Reason (Malaria) | active | 2017-01 | tho oid | |||
| hl7.fhir.us.registry-protocols | R4 | PriorDiagnosticCoronaryAngiographyProcedureResults | Prior Diagnostic Coronary Angiography Procedure Results | active | cic | 2023-11 | hl7 | fhir sct | |
| us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1010.2 | Clinical Substance | active | 2024-06 | hl7 | vsac | ||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.6000 | Problem Goal Action Code (HL7) | active | 2011-01 | tho | |||
| fhir.cdc.opioid-cds-r4 | R4 | condition-problem-list-category | Problem List Condition Category | active | 2023-05 | hl7 | |||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.88.12.3221.7.4 | Problem | active | 2024-06 | hl7 | sct | ||
| signal.core.r4 | R4 | procedure-category | Procedure Category Codes (SNOMED CT) | draft | 1 | pc | 2019-10 | hl7 | sct |
| hl7.fhir.us.davinci-pct | R4 | ICD10ProcedureCodes | ICD-10 Procedure Codes | trial-use | fm | 2025-06 | hl7 | cms | |
| fhir.cdc.opioid-cds-r4 | R4 | observation-category-procedure | Observation Category Procedure | active | 2023-05 | hl7 | |||
| signal.core.r4 | R4 | procedure-outcome | Procedure Outcome Codes (SNOMED CT) | draft | 1 | pc | 2019-10 | hl7 | sct |
| fhir.cdc.opioid-cds-r4 | R4 | hospice-procedure | Hospice Procedure | active | 2023-05 | hl7 | sct | ||
| signal.core.r4 | R4 | procedure-followup | Procedure Follow up Codes (SNOMED CT) | draft | 1 | pc | 2019-10 | hl7 | sct |
| fhir.cdc.opioid-cds-r4 | R4 | pdmp-review-procedure | PDMP review procedure | active | 2023-05 | hl7 | sct | ||
| fhir.cdc.opioid-cds-r4 | R4 | opioid-counseling-procedure | Opioid counseling procedure | active | 2023-05 | hl7 | sct | ||
| fhir.cdc.opioid-cds-r4 | R4 | pain-management-procedure | Pain management procedure | active | 2023-05 | hl7 | sct | ||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7991 | Procedure Type (Anthrax) | active | 2020-01 | sct tho | |||
| fhir.cdc.opioid-cds-r4 | R4 | opioid-misuse-assessment-procedure | Opioid misuse assessment procedure | active | 2023-05 | hl7 | sct | ||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.1109 | Procedure by Site (SNOMED) | active | 2008-01 | sct | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.3226 | Blood or body fluid exposure related procedure | active | 2009-01 | sct | |||
| hl7.fhir.us.birthdefectreporting | R4 | bdr-procedurelist | Newborn Procedure List | draft | pher | 2025-06 | hl7 | cdc sct | |
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7938 | Detection Method (COVID-19) | active | 2020-01 | tho oid | |||
| signal.core.r4 | R4 | questionnaire-dacods-discharge-progress-towards-measurable-treatment-goals | Questionnaire DACODS Discharge Progress Towards Measurable Treatment Goals | draft | 1 | pa | hl7 | ||
| signal.core.r4 | R4 | progress-made-towards-goals | Progress Made Towards Goals | draft | 1 | pa | hl7 | ||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7810 | Provider Information Source (RIBD) | active | 2018-01 | sct tho | |||
| fhir.argonaut.r2 | R2 | provider-role | Care Team Provider Roles | draft | 2016-10 | hl7 | nucc sct | ||
| fhir.argonaut.pd | R3 | provider-role | Argonaut Provider Directory Provider Role (NUCC) | draft | 2016-08 | hl7 | nucc | ||
| fhir.argonaut.pd | R3 | provider-specialty | Argonaut Provider Directory Provider Speciality (NUCC) | draft | 2016-08 | hl7 | nucc | ||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.3108 | Travel Purpose | active | 2008-01 | sct tho oid | |||
| hl7.fhir.us.breast-radiology | R4 | rde1563-quadrant | RDE1563 Quadrant | draft | 2022-12 | hl7 | fhir | ||
| hl7.fhir.us.davinci-drug-formulary | R4 | CoinsuranceOptionVS | Qualifier for coinsurance rate | trial-use | phx | 2025-02 | hl7 | fhir | |
| hl7.fhir.us.Davinci-drug-formulary | R4 | usdf-CoinsuranceOptionVS | Coinsurance Option VS | draft | 2020-01 | hl7 | fhir | ||
| hl7.fhir.us.davinci-drug-formulary | R4 | CopayOptionVS | Qualifier of copay amount | trial-use | phx | 2025-02 | hl7 | fhir | |
| hl7.fhir.us.Davinci-drug-formulary | R4 | usdf-CopayOptionVS | Copay Option VS | draft | 2020-01 | hl7 | fhir | ||
| hl7.fhir.us.codex-radiation-therapy | R4 | codexrt-disease-progression-qualifier-vs | Disease Progression Qualifier Value Set | active | cgp | 2025-02 | hl7 | sct | |
| hl7.fhir.us.codex-radiation-therapy | R4 | codexrt-intrafraction-verification-qualifier-vs | Intrafraction Verification Procedure Qualifier Value Set | active | cgp | 2025-02 | hl7 | sct | |
| hl7.fhir.us.mcode | R4 | mcode-body-location-qualifier-vs | Body Location Qualifier Value Set | active | 4 | cic | 2025-02 | hl7 | fhir |
| hl7.fhir.us.mcode | R4 | mcode-body-location-and-laterality-qualifier-vs | Body Location and Laterality Qualifier Value Set | active | 4 | cic | 2025-02 | hl7 | sct |
| hl7.fhir.us.mcode | R4 | mcode-laterality-qualifier-vs | Laterality Qualifier Value Set | active | 4 | cic | 2025-02 | hl7 | sct |
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.1014 | Modifier or Qualifier | active | 2010-01 | sct | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7227 | VDRL Test Result (NND) | active | 2020-01 | sct tho | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7206 | Lab Test Result Qualitative (NND) | active | 2020-01 | sct tho oid | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7928 | Lab Test Result Qualitative (Syphilis) | active | 2019-12 | sct tho oid | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.3265 | Positive Negative Unknown | active | 2009-01 | sct tho | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7203 | Quantitative Syphilis Test Result (STD) | active | 2020-01 | sct tho oid | |||
| hl7.fhir.us.davinci-dtr | R4 | MetricsinformationOrigins | Information Human Origins Value Set | trial-use | 2 | cds | 2025-07 | hl7 | fhir |
| us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1260.242 | RET Test (HGNC) | active | 2024-06 | hl7 | sct | ||
| us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1260.245 | RET Negative (geneinterpretaion) SNOMED | active | 2024-06 | hl7 | sct | ||
| us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1260.244 | RET Gene Rearrangement | active | 2024-06 | hl7 | sct | ||
| us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1260.243 | RET Positive (Genei interpretation ) | active | 2024-06 | hl7 | sct | ||
| signal.core.r4 | R4 | questionnaire-ccars-race | Questionnaire CCARS Race | draft | 1 | pa | hl7 | ||
| us.nlm.vsac | R4 | 1.3.6.1.4.1.6997.4.1.2.265.15.31305.1.11.1.999.188 | Radiotherapy | active | 2017-03 | hl7 | sct | ||
| us.nlm.vsac | R4 | 1.3.6.1.4.1.6997.4.1.2.265.15.31305.1.11.1.999.189 | Radiotherapy | active | 2017-03 | hl7 | icd | ||
| hl7.fhir.us.mcode | R4 | mcode-rai-staging-method-vs | Rai Staging System Value Set | active | cic | 2025-02 | hl7 | ncit sct | |
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.1021 | Number Of Lesions (VZ) | active | 2008-01 | tho oid | |||
| signal.core.r4 | R4 | questionnaire-ccars-overall-symptom-severity-rating | Questionnaire CCARS Overall Symptom Severity Rating | draft | 1 | pa | hl7 | ||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7937 | Case Probable Reason (COVID-19) | active | 2020-01 | oid | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7632 | Raw Unpasteurized Products (FDD) | active | 2017-01 | tho oid | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7217 | Lab Test Reactivity (NND) | active | 2020-01 | sct tho | |||
| us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1254.1 | EventTiming-TimingEvent | active | 2024-05 | hl7 | tho | ||
| us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1254.2 | EventTiming-EventTiming | active | 2024-05 | hl7 | fhir | ||
| us.nlm.vsac | R4 | event-timing | EventTiming | normative | 5 | fhir | 2023-03 | hl7 | fhir tho |
| signal.core.r4 | R4 | reason-for-discharge | Reason For Discharge | active | 2023-06 | hl7 | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7756 | Reason LTBI Not Started (TB) | active | 2018-01 | sct tho oid | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7757 | Reason LTBI Treatment Stopped (TB) | active | 2017-12 | sct tho oid | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7767 | Reason Not Treated with RIPE (TB) | active | 2018-01 | sct tho oid | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.1051 | Substance Treatment Refusal Reason | active | 2008-01 | sct tho oid | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7695 | Antibiotic Reason (RIBD) | active | 2018-01 | sct tho oid | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7269 | Reason for Missing Test (NND) | active | 2020-01 | sct tho oid | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.3310 | Medication Missed (Malaria) | active | 2010-01 | sct tho oid | |||
| hl7.fhir.us.davinci-ra | R4 | remark-reason | Remark Reason | trial-use | 2 | cqi | 2025-06 | hl7 | fhir |
| hl7.fhir.us.davinci-deqm | R4 | remark-reason | Remark Reason | trial-use | 4 | cqi | 2025-07 | hl7 | fhir |
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7738 | Isolate Not Available (RIBD) | active | 2018-01 | sct oid | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.1013 | Missing Lab Result Reason | active | 2008-01 | sct tho oid | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.3134 | No Case Reason (CRS) | active | 2008-01 | sct tho oid | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.8002 | Reason Medication Not Completed (BSP) | active | 2020-01 | sct tho oid | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7699 | Susceptibility Data NA (RIBD) | active | 2018-01 | sct tho oid | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.1050 | Batch Deactivation Reason | active | 2008-01 | tho oid | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.3157 | RVCT Link Reason (TB) | active | 2008-01 | oid | |||
| fhir.nigeriaImmunization | R4 | NEIRImmunizationNotDoneReasonsVS | Reason Vaccine not administered | draft | 2025-05 | hl7 | |||
| hl7.fhir.us.davinci-crd | R4 | coverageAssertionReasons | CRD Coverage Assertion Reasons | trial-use | 1 | fm | 2025-07 | hl7 | fhir |
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.991 | Environmental Investigation Reason | active | 2008-01 | sct tho oid | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7799 | Reason Not Interviewed (Listeria) | active | 2018-01 | tho oid | |||
| hl7.fhir.us.registry-protocols | R4 | PCIIndications | Percutaneous Coronary Intervention Indication | active | cic | 2023-11 | hl7 | fhir sct | |
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.931 | Vaccine Not Given Reason | active | 2021-01 | sct tho oid | |||
| hl7.fhir.us.vdor | R4 | vdor-recent-emergency-department-visit-vs | VDOR Recent Emergency Department Visit or Urgent Care Visit | informative | pher | 2025-06 | hl7 | fhir | |
| hl7.fhir.us.military-service | R4 | military-service-deployment-episode-mission-vs | Deployment Episode Type Value Set | active | 2023-05 | hl7 | fhir | ||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7703 | MIC Operator (RIBD) | active | 2018-01 | sct | |||
| us.cdc.phinvads | R4 | 2.16.840.1.113883.3.520.4.25 | Radiation Rx and Boost Radiation ICD10-PCS (NAACCR | active | 2015-01 | cms | |||
| us.cdc.phinvads | R4 | 2.16.840.1.113883.3.520.4.26 | Radiation Rx and Boost Radiation SNOMEDCT (NAACCR) | active | 2015-01 | sct | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7194 | Drugs Used (STD) | active | 2019-12 | sct rx tho oid | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7631 | Recreational H2O Treatment (FDD) | active | 2017-01 | tho oid | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.3098 | Recreational Water (FDD) | active | 2008-01 | sct tho oid | |||
| hl7.fhir.us.ccda | R4 | 2.16.840.1.113883.1.11.20.2.3 | ReferralDocumentType | active | cgp | 2018-05 | hl7 | loinc | |
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7791 | Hispanic Ethnic Group (Listeria) | active | 2018-01 | tho oid | |||
| hl7.fhir.us.breast-radiology | R4 | rde1564-region | RDE1564 Region | draft | 2022-12 | hl7 | fhir | ||
| us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1166.115 | Self Identified Need for Contraception (SINC) | active | 2021-10 | hl7 | loinc | ||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.813 | Relationship (HL7) | active | 2015-01 | tho | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.3275 | Relationship (Flu) | active | 2009-01 | sct tho | |||
| us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1010.9 | Substance Other Than Clinical Drug | active | 2024-06 | hl7 | sct | ||
| hl7.fhir.us.vrdr | R4 | vrdr-replace-status-vs | Replacement Status ValueSet | active | pher | 2024-10 | hl7 | fhir | |
| us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1032.231 | Gestational Diabetes ICD10CM | active | 2023-03 | hl7 | icd | ||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.1025 | Order Status (HL7) | active | 2008-01 | tho | |||
| us.nlm.vsac | R4 | 2.16.840.1.113883.1.11.20.12 | HealthStatus | active | 2023-07 | hl7 | sct | ||
| us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1146.1210 | Enterobacter spp., E. coli, or Klebsiella spp. (Organism or Substance in Lab Results) | active | 2023-01 | hl7 | sct | ||
| hl7.fhir.us.daf | R3 | daf-research-data-models | DAF Research Data Models | active | 2016-07 | hl7 | fhir | ||
| hl7.fhir.us.daf | R3 | daf-research-query-formats | DAF Research Query Formats | active | 2016-07 | hl7 | fhir | ||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7730 | Residence Location (RIBD) | active | 2018-01 | cdc sct tho oid | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7725 | Respiratory Protective Equipment (RIBD) | active | 2018-01 | sct tho oid | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7720 | Water Source (RIBD) | active | 2018-01 | sct tho oid | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.1023 | Response Flag (HL7) | active | 2008-01 | tho | |||
| hl7.fhir.us.davinci-crd | R4 | coverageClass | CRD Coverage Classes Value Set | trial-use | 3 | fm | 2025-07 | hl7 | tho |
| fhir.virtually.healthcare | R4 | PatientReferral | Patient Referral | draft | 2025-07 | hl7 | sct | ||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.3428 | Result Status (NETSS) | active | 2011-01 | oid | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7224 | Darkfield DFA Result (CS) | active | 2020-01 | sct tho oid | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7746 | Result of Radiology Study (TB) | active | 2017-12 | sct tho oid | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7862 | Test Result (CP-CRE) | active | 2018-01 | sct tho | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7814 | Genotypic Test Result (CP-CRE) | active | 2018-01 | sct | |||
| hl7.fhir.us.mcode | R4 | mcode-tnm-distant-metastases-category-vs | TNM Distant Metastases Category Value Set | active | 4 | cic | 2025-02 | hl7 | sct |
| hl7.fhir.us.mcode | R4 | mcode-tnm-regional-nodes-category-vs | TNM Regional Nodes Category Value Set | active | 4 | cic | 2025-02 | hl7 | sct |
| hl7.fhir.us.mcode | R4 | mcode-tnm-primary-tumor-category-vs | TNM Primary Tumor Category Value Set | active | 4 | cic | 2025-02 | hl7 | sct |
| hl7.fhir.us.mcode | R4 | mcode-tnm-stage-group-vs | TNM Stage Group Value Set | active | 4 | cic | 2025-02 | hl7 | sct |
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7102 | VPD Lab Test Identifiers | active | 2020-01 | oid loinc | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.3019 | Resulted Lab Test Name (PHLIP Flu) | active | 2019-01 | oid loinc | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7919 | CPO PCR result (ARLN) | active | 2019-01 | sct | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.8000 | Test Results Anthrax | active | 2020-01 | sct tho | |||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.67.1.101.1.2433 | Delivery | active | 2024-07 | hl7 | cms | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.67.1.101.1.2435 | HBsAg | active | 2024-07 | hl7 | cpt | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.67.1.101.1.273 | Live Birth or Delivery | active | 2024-07 | hl7 | vsac | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.67.1.101.1.274 | Live Birth or Delivery I10 | active | 2024-07 | hl7 | icd | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.67.1.101.1.275 | Live Birth or Delivery | active | 2024-07 | hl7 | sct | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.67.1.101.1.277 | Delivery | active | 2024-07 | hl7 | cpt | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.67.1.101.1.278 | Delivery - Diagnosis | active | 2024-07 | hl7 | vsac | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.67.1.101.1.279 | HBsAg | active | 2024-07 | hl7 | vsac | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.67.1.101.1.281 | HBsAg | active | 2024-07 | hl7 | loinc | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.67.1.101.1.82 | Delivery | active | 2024-07 | hl7 | sct | ||
| us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.113 | Chronic kidney disease SCT | active | 2024-06 | hl7 | sct | ||
| us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.116 | DigTx Cognitive Impairment I10 | active | 2024-06 | hl7 | icd | ||
| us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.117 | DigTx Cognitive Impairment SCT | active | 2024-08 | hl7 | sct | ||
| us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.124 | DKD | active | 2024-08 | hl7 | vsac | ||
| us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.147 | HFrEF SCT | active | 2025-02 | hl7 | sct | ||
| us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.148 | HFrEF I10 | active | 2024-07 | hl7 | icd | ||
| us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.150 | History of Hypoglycemia I10 | active | 2024-08 | hl7 | icd | ||
| us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.151 | History of Hypoglycemia SCD | active | 2024-08 | hl7 | sct | ||
| us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.153 | Hyperlipidemia | active | 2024-08 | hl7 | icd | ||
| us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.21 | Thoracic aorta disease | active | 2024-08 | hl7 | sct | ||
| us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.3 | Delivery I10 | active | 2024-08 | hl7 | icd | ||
| us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.37 | relatedconditions_hypertension SCT | active | 2024-08 | hl7 | sct | ||
| us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.5 | Delivery - Procedure | active | 2024-07 | hl7 | vsac | ||
| us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.85 | PCSK9i | active | 2024-07 | hl7 | rx | ||
| us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.88 | DEPRECATED Diabetes | active | 2024-07 | hl7 | vsac | ||
| us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.95 | Albuminuria | active | 2024-07 | hl7 | vsac | ||
| us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.96 | AlcoholicLiverDisease I10 | active | 2024-07 | hl7 | icd | ||
| us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.99 | BMI SCT | active | 2024-07 | hl7 | sct | ||
| us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.92 | ASCVD | active | 2024-07 | hl7 | vsac | ||
| us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.17 | Atrial fibrillation | active | 2024-08 | hl7 | sct | ||
| us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.45 | ACE inhibitor allergy RXNORM | active | 2024-12 | hl7 | rx | ||
| us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.94 | Albuminuria SCT | active | 2024-07 | hl7 | sct | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.11.20.9.35 | Pressure Ulcer Stage | active | 2023-07 | hl7 | sct | ||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.1037 | Risk Category | active | 2008-01 | sct tho oid | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7966 | Rodent Type (Leptospirosis) | active | 2020-01 | sct tho | |||
| hl7.fhir.us.vrdr | R4 | vrdr-transportation-incident-role-vs | Transportation Incident Role ValueSet | active | pher | 2024-10 | hl7 | sct tho |
FHIR